2000
DOI: 10.1016/s0887-2333(00)00010-2
|View full text |Cite
|
Sign up to set email alerts
|

Polar application of test substances in an organotypic environment and under continuous medium flow: A new tissue-based test concept for a broad range of applications in pharmacotoxicology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…Notable is the effort to establish patient-specific therapeutic test systems for specific tumor entities, such as the ex vivo ATP-based chemosensitivity assay (ATP-TCA), which is based on the 2-D culturing of tumor cells isolated from primary tissue biopsies. [26][27][28][29] Also, in parallel to improvements in the tissue engineering field, diverse culture approaches have been developed that may allow reproducible maintenance of viability and differentiation in isolated primary tissue material of different origin in a 3-D format, such as the NASA bioreactor, [30][31][32][33] various perfusion-type or gradient container systems, [34][35][36][37][38][39][40][41] or the tumor fragment spheroid model. [42][43][44] Some of the above-mentioned systems are still under refinement to better match specific properties of differentiated tissues.…”
Section: Rationale For Using Complex Cell Systems In Antitumor Drug Testingmentioning
confidence: 99%
“…Notable is the effort to establish patient-specific therapeutic test systems for specific tumor entities, such as the ex vivo ATP-based chemosensitivity assay (ATP-TCA), which is based on the 2-D culturing of tumor cells isolated from primary tissue biopsies. [26][27][28][29] Also, in parallel to improvements in the tissue engineering field, diverse culture approaches have been developed that may allow reproducible maintenance of viability and differentiation in isolated primary tissue material of different origin in a 3-D format, such as the NASA bioreactor, [30][31][32][33] various perfusion-type or gradient container systems, [34][35][36][37][38][39][40][41] or the tumor fragment spheroid model. [42][43][44] Some of the above-mentioned systems are still under refinement to better match specific properties of differentiated tissues.…”
Section: Rationale For Using Complex Cell Systems In Antitumor Drug Testingmentioning
confidence: 99%
“…Most of the administered pharmaceuticals have to pass an epithelial barrier in the organism. To test the transport of newly developed drugs through an epithelial cell layer long term gradient perfusion culture experiments were performed [99,100]. In these series of experiments it was found that Caco‐2 cells are forming a tightly sealing epithelial cell layer [101,102].…”
Section: Reviewmentioning
confidence: 99%
“…Pharmaceuticals were applied in gradient perfusion culture [71,[96][97][98]. It was found for example that the gradient perfusion culture with Caco-2 cells generated sealing epithelia and revealed reproducible results much earlier than traditional 21-day static cultures.…”
Section: Pharmaceutical Applicationmentioning
confidence: 99%